Emcure Pharma Q3 Results: Strong operating performance but stock gives up gains

According to Emcure Pharma, profit growth was driven by strong traction across key therapies in India and sustained momentum in overseas markets.

Leave a Reply

Your email address will not be published. Required fields are marked *